Karyopharm Therapeutics | KPTI - 销售毛利

金融业

USD

USD 108.42M

现金及等价物

USD 60.54M

USD 1.48M

USD 103.15M

USD 92.06M

USD 299.23M

股息收益率

0

USD -17.84M

USD -26.2M

325

EPS每股收益

USD -2.22

股本和储备

USD -292.93M

USD 32.6M

债务利息支出

USD 12.62M

USD -0.15

USD 278.22M

USD 938.9M

USD -102.2M

USD 51.92M

USD -17.84M

普通股股本

USD 18.31M

USD -39.9M

USD 34.08M

销售和管理费用

USD 9.56M

USD 4.04M

贸易债权人

USD 4M

应收帐款人

USD 26.18M

	销售毛利	更改		日
AbbVie	USD 12.54B		474M	2026-03
Abbott	USD 5.86B		675M	2026-03
Amgen	USD 6.89B		415M	2025-12
AstraZeneca	USD 12.61B		225M	2026-03
BioCryst Pharmaceuticals	USD 153.05M		4.16M	2025-12
Bristol-Myers Squibb	USD 8.41B		381M	2025-12
Eli Lilly	USD 15.92B		1.33B	2025-12
Enanta Pharmaceuticals	-22.29M		23.75M	2024-12
GlaxoSmithKline	GBP 5.75B		429M	2026-03
Incyte	USD 1.17B		217.51M	2026-03
J&J	USD 17.24B		642M	2026-03
Karyopharm Therapeutics	USD 32.6M		63.38M	2025-12
MacroGenics	USD 31.11M		30.14M	2025-12
Merck	USD 10.85B		2.57B	2025-12
Nektar Therapeutics	USD 21.81M		8.06M	2025-12
Novartis	USD 10.07B		184M	2026-03
Novartis	USD 10.82B		694M	2025-09
Pfizer	USD 11.04B		1.24B	2026-03
Regeneron Pharmaceuticals	USD 2.94B		363.7M	2026-03
Roche Holding	CHF 22.09B		10.04B	2025-12
Sangamo BioSciences	-2.39M		1.09M	2024-06
Takeda	JPY 688.84B		101.71B	2026-03
Tectonic Therapeutic	USD 0		0	2025-03
TG Therapeutics	USD 171.41M		16.98M	2026-03
Ultragenyx Pharmaceutical	USD 106M		72M	2026-03
Xencor	USD 21M		22.61M	2025-09